Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4849265
Max Phase: Preclinical
Molecular Formula: C15H14N6O10S2
Molecular Weight: 502.44
Molecule Type: Unknown
Associated Items:
ID: ALA4849265
Max Phase: Preclinical
Molecular Formula: C15H14N6O10S2
Molecular Weight: 502.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc(/C(=N/OCC(=O)O)C(=O)N[C@@H]2C(=O)N3[C@@H]2[S@@+]([O-])C[C@@H]2CC(=O)O[C@@]23C(=O)O)ns1
Standard InChI: InChI=1S/C15H14N6O10S2/c16-14-18-9(20-32-14)7(19-30-2-5(22)23)10(25)17-8-11(26)21-12(8)33(29)3-4-1-6(24)31-15(4,21)13(27)28/h4,8,12H,1-3H2,(H,17,25)(H,22,23)(H,27,28)(H2,16,18,20)/b19-7-/t4-,8+,12+,15+,33-/m0/s1
Standard InChI Key: KWRDULPOBLZFNN-IRCGDWLSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 502.44 | Molecular Weight (Monoisotopic): 502.0213 | AlogP: -3.31 | #Rotatable Bonds: 7 |
Polar Surface Area: 246.76 | Molecular Species: ACID | HBA: 13 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.11 | CX Basic pKa: 0.07 | CX LogP: -1.94 | CX LogD: -9.06 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.09 | Np Likeness Score: 0.07 |
1. Sato J, Kusano H, Aoki T, Shibuya S, Yokoo K, Komano K, Oguma T, Matsumoto S, Sato T, Yasuo K, Yamawaki K.. (2021) A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships., 46 [PMID:34450571] [10.1016/j.bmc.2021.116343] |
Source(1):